Latest News

January 26, 2012
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.
January 17, 2012
Scientists from the University of Helsinki, Finland, and UCSF have identified a cleaver-wielding protein that frees some tumor cells, allowing them to further misbehave. The discovery points to a new target for therapy.
December 23, 2011
A cancer drug company founded by UCSF Professor Kevan Shokat, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.
December 12, 2011
UCSF Nobel laureate Elizabeth Blackburn, PhD, whose co-discovery of an enzyme involved in cell aging and cancers opened a whole new field of scientific inquiry, was inducted into the California Hall of Fame on Dec. 8, 2011. 
December 06, 2011
A UCSF study suggests patients with chronic pain may experience greater relief if their doctors add cannabinoids – the main ingredient in cannabis or medical marijuana – to an opiates-only treatment.
November 14, 2011
UCSF oncologist Pamela Munster, MD, and her colleagues have discovered the molecular basis for tamoxifen resistance in women with breast cancer and found a potential way to defeat it by administering a second class of drugs.
November 14, 2011
UCSF’s Carol Franc Buck Breast Care Center is holding “Taste for the Cure: A Taste of Science,’’ a day for exploring the impact that food and science have on breast health.
October 27, 2011
A large, international clinical trial led by doctors at UCSF indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the October 27, 2011 issue of New England Journal of Medicine.
October 26, 2011
Three UCSF volunteers are leading a $25-million fundraising campaign to raise funds for brain cancer treatment and research.
October 25, 2011
Former Wall Street executive Gordon Murray, a former patient UCSF, wrote a book after battling brain cancer for more than a year, knowing that he had only a few months to live when he started it.

Pages